
Immutep Limited IMMP
$ 0.36
-7.04%
Annual report 2025
added 03-21-2026
Immutep Limited P/S Ratio 2011-2026 | IMMP
Annual P/S Ratio Immutep Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 492 | 7.63 | 7.76 | 6.57 | - | 526 | - | - | - | 122 | - |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 526 | 6.57 | 194 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Lipocine
LPCN
|
-6.71 | $ 7.4 | 1.23 % | $ 39 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 217.23 | -0.38 % | $ 5 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 19.47 | 1.25 % | $ 910 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
2.86 | $ 8.28 | -1.84 % | $ 110 M | ||
|
Lexicon Pharmaceuticals
LXRX
|
11.9 | $ 1.68 | 2.13 % | $ 610 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
10.4 | $ 0.74 | 21.89 % | $ 8.48 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Exelixis
EXEL
|
5.05 | $ 41.51 | 0.23 % | $ 11.3 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.36 | -3.21 % | $ 347 M | ||
|
MediWound Ltd.
MDWD
|
6.04 | $ 16.64 | -1.42 % | $ 453 M | ||
|
Mesoblast Limited
MESO
|
127 | $ 14.31 | 2.07 % | $ 9.29 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
Genmab A/S
GMAB
|
15.6 | $ 25.73 | 0.19 % | $ 16.5 B | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.61 | -0.76 % | $ 16.4 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
60.1 | $ 4.34 | -1.92 % | $ 832 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Ionis Pharmaceuticals
IONS
|
63.5 | $ 69.55 | -1.75 % | $ 11.1 B | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Longeveron
LGVN
|
14.1 K | $ 0.87 | -8.8 % | $ 15.3 B |